Search Within

David Lebwohl

Formats
  1. Journal Article (18)
  2. Meeting Abstract (7)
  3. Conference Paper (3)
Groups
  1. Breast Medicine Service (22)
  2. Department of Medicine (22)
  3. Solid Tumor Oncology Division (22)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (14)
  5. Behavioral Sciences Service (14)
  6. Psychiatry and Behavioral Sciences, Department of (14)

More Groups

People
  1. Andrew Seidman (14)
  2. Clifford Hudis (14)
  3. Larry Norton (14)
  4. Teresa Gilewski (14)
  5. Violante Currie (13)
  6. Tzy-Jyun Yao (12)

More People

Years
  1. 1999 (2)
  2. 1998 (1)
  3. 1996 (3)
  4. 1995 (4)
  5. 1994 (8)
  6. 1993 (5)

More Years

Publications
  1. Journal of Biological Chemistry (4)
  2. Journal of Clinical Oncology (4)
  3. Journal of Cellular Biochemistry (3)
  4. Seminars in Oncology (3)
  5. Breast Cancer Research and Treatment (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Society for Biochemistry and Molecular Biology (4)
  2. American Society of Clinical Oncology (4)
  3. John Wiley & Sons (4)
  4. American Association for Cancer Research (3)
  5. Elsevier Inc. (3)
  6. Wiley Blackwell (3)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activation of normal ras by receptor tyrosine kinases is required for the malignant phenotype of breast cancer cells
    Meeting Abstract

    Anelli, A.; Sepp-Lorenzino, L.; Baselga, J.; Borgen, P.; Rosen, N.; Lebwohl, D. E.
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • A truncated cyclin D1 transcript is overexpressed in a human breast cancer cell line bearing an altered D1 gene
    Meeting Abstract

    Lebwohl, D. E.; Muise-Helmericks, R.; Sepp-Lorenzino, L.; Serve, S.; Borgen, P.; Rosen, N.
    Journal of Cellular Biochemistry (1994)

    Fulltext@MSK | Save
  • Herbimycin A inhibits the IGF-I receptor protein tyrosine kinase and cellular proliferation in human breast cancer cells
    Meeting Abstract

    Sepp-Lorenzino, L.; Ma, Z. P.; Rosen, N.; Lebwohl, D. E.
    Journal of Cellular Biochemistry (1994)

    Fulltext@MSK | Save
  • Results of sequential dose-intensive adjuvant therapy with doxorubicin and cyclophosphamide
    Meeting Abstract

    Hudis, C.; Lebwohl, D.; Yao, T. J.; Crown, J.; Gilewski, T.; Currie, V.; Raptis, G.; Seidman, A.; Fennelly, D.; Kesselman, E.; more...
    Breast Cancer Research and Treatment (1994)

    Fulltext@MSK | Save
  • Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer
    Conference Paper

    Seidman, A. D.; Norton, L.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Hudis, C. A.; Surbone, A.; more...
    S. Karger AG (1994)

    Fulltext@MSK | Save
  • A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line
    Journal Article

    Lebwohl, D. E.; Muise-Helmericks, R.; Sepp-Lorenzino, L.; Serve, S.; Timaul, M.; Bol, R.; Borgen, P.; Rosen, N.
    Oncogene (1994)

    Fulltext@MSK | Save
  • Insulin and insulin-like growth factor signaling are defective in the MDA MB-468 human breast cancer cell line
    Journal Article

    Sepp-Lorenzino, L.; Rosen, N.; Lebwohl, D. E.
    Cell Growth & Differentiation (1994)

    Fulltext@MSK | Save
  • Tamoxifen adminstration is associated with a high rate of treatment‐limiting symptoms in male breast cancer patients
    Journal Article

    Moredo Anelli, T. F.; Anelli, A.; Tran, K. N.; Lebwohl, D. E.; Borgen, P. I.
    Cancer (1994)

    Fulltext@MSK | Save
  • Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
    Journal Article

    Reichman, B. S.; Seidman, A. D.; Crown, J. P. A.; Heelan, R.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; Currie, V.; Hudis, C. A.; more...
    Journal of Clinical Oncology (1993)

    Fulltext@MSK | Save
  • Preliminary experience with paclitaxel (TAXOL®) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer
    Conference Paper

    Seidman, A. D.; Norton, L.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Heelan, R.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Surbone, A.; more...
    Elsevier Inc. (1993)

    Fulltext@MSK | Save